Stock of the Day: What’s Ahead for Bioamber Inc After Today’s Huge Decline?

Stock of the Day: What's Ahead for Bioamber Inc After Today's Huge Decline?

The stock of Bioamber Inc (NYSE:BIOA) is a huge mover today! The stock decreased 4.46% or $0.21 on November 4, hitting $4.5. About 107,948 shares traded hands or 78.44% up from the average. Bioamber Inc (NYSE:BIOA) has risen 12.14% since April 4, 2016 and is uptrending. It has outperformed by 11.05% the S&P500.
The move comes after 7 months negative chart setup for the $129.77M company. It was reported on Nov, 4 by Barchart.com. We have $3.87 PT which if reached, will make NYSE:BIOA worth $18.17 million less.

According to Zacks Investment Research, “BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.”

Insitutional Activity: The institutional sentiment decreased to 0.82 in 2016 Q2. Its down 0.43, from 1.25 in 2016Q1. The ratio worsened, as 2 funds sold all Bioamber Inc shares owned while 9 reduced positions. 1 funds bought stakes while 8 increased positions. They now own 11.17 million shares or 8.33% less from 12.19 million shares in 2016Q1.
Toronto Dominion Fincl Bank holds 5,000 shares or 0% of its portfolio. Waddell & Reed Inc last reported 0.05% of its portfolio in the stock. Raymond James Svcs Advsrs Incorporated has 31,627 shares for 0% of their US portfolio. Morgan Stanley holds 12,252 shares or 0% of its portfolio. Blackrock Fund accumulated 0% or 3,413 shares. Levin Strategies L P accumulated 0.01% or 191,677 shares. Robecosam Ag reported 400,000 shares or 0.11% of all its holdings. Goldman Sachs Gp, a New York-based fund reported 10,786 shares. Blackrock Institutional Com Na last reported 137,711 shares in the company. Geode Mgmt Ltd Llc has invested 0% of its portfolio in Bioamber Inc (NYSE:BIOA). Financial Bank Of America De has 3,537 shares for 0% of their US portfolio. Winslow Evans Crocker has invested 0% of its portfolio in Bioamber Inc (NYSE:BIOA). Bridgeway Mngmt Inc holds 0% of its portfolio in Bioamber Inc (NYSE:BIOA) for 76,700 shares. Moreover, Comml Bank Of New York Mellon Corporation has 0% invested in Bioamber Inc (NYSE:BIOA) for 15,311 shares. Moreover, Royal Natl Bank Of Canada has 0% invested in Bioamber Inc (NYSE:BIOA) for 5,949 shares.

Insider Transactions: Since May 5, 2016, the stock had 4 insider buys, and 0 selling transactions for $152,787 net activity. $10,315 worth of Bioamber Inc (NYSE:BIOA) was bought by Hartmann Michael A. on Thursday, May 5. Another trade for 1,000 shares valued at $3,691 was bought by BRINER KURT W. 13,227 shares with value of $41,136 were bought by Wall Kenneth W. on Monday, May 9. The insider Huc Jean-Francois bought $32,190.

More recent Bioamber Inc (NYSE:BIOA) news were published by: Quotes.Wsj.com which released: “BioAmber Inc. BIOA (US: NYSE)” on April 27, 2013. Also Reuters.com published the news titled: “BRIEF-Bioamber Inc reports Q3 loss per share $0.21” on November 03, 2016. Prnewswire.com‘s news article titled: “BioAmber Reports Third Quarter 2016 Financial and Operational Results” with publication date: November 03, 2016 was also an interesting one.

BIOA Company Profile

BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., incorporated on October 15, 2008, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, resins, food additives and personal care products. The Company’s geographical divisions include Europe and North America. The Firm sells its product, bio-succinic acid, to clients in a range of chemical markets. Bio-succinic acid is a biologically produced, chemically identical replacement for petroleum-derived succinic acid that can be utilized to produce derivative products, such as bio 1,4 Butanediol (1,4 BDO), and can substitute petrochemicals, such as maleic anhydride, phthalic acid and adipic acid in various applications. The Company’s bio specialty chemicals can be used in multiple end-markets and applications, and serves as building blocks for a range of products used every day. Bio-succinic acid is used in various applications, including plasticizers, polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals and lubricants, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate (PET).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment